| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/16/2013 | US8420591 MUC1 and galectin-3 |
| 04/16/2013 | US8420590 Genes and proteins that home to developing microvessels |
| 04/16/2013 | US8420396 For delivering DNA/RNA into cells |
| 04/16/2013 | US8420391 RNA sequence-specific mediators of RNA interference |
| 04/16/2013 | US8420350 Glycosylation-deficient hepatocyte growth factor |
| 04/16/2013 | US8420340 Identification of Actinobacillus actinomycetemcomitans antigens for use in the diagnosis, treatment, and monitoring of periodontal diseases |
| 04/16/2013 | US8420309 Method of screening compounds using CALHM (FAM26C) |
| 04/16/2013 | US8420135 Use of coconut water extract or coconut shell extract for treating immunological diseases and/or disorders |
| 04/16/2013 | US8420130 Pharmaceutical formulation of a didemnin compound |
| 04/16/2013 | US8420105 Botulinum toxin administration to treat various conditions |
| 04/16/2013 | US8420096 Cell-penetrating SOCS polypeptides that inhibit cytokine-induced signaling |
| 04/16/2013 | US8420095 Antigen-containing microspheres for the treatment of allergies |
| 04/16/2013 | US8420088 Methods and compositions using FGF23 fusion polypeptides |
| 04/16/2013 | US8420081 Antibody formulations and methods of making same |
| 04/16/2013 | US8420080 Methods for treating adult respiratory distress syndrome |
| 04/16/2013 | US8420079 Recombinantly modified plasmin |
| 04/16/2013 | US8420071 Herpes simplex virus expressing foreign genes and method for treating cancers therewith |
| 04/16/2013 | US8420067 Targeted polylysine dendrimer therapeutic agent |
| 04/16/2013 | US8420051 Muteins of hNGAL and related proteins with affinity for a given target |
| 04/16/2013 | CA2628315C Compositions and methods for the detection of trypanosoma cruzi infection |
| 04/16/2013 | CA2614820C Method for purifying g-csf |
| 04/16/2013 | CA2574564C Use of il-28 and il-29 to treat cancer and autoimmune disorders |
| 04/16/2013 | CA2573207C Use of a combination of cyclosporin and pegylated interferons for treating hepatitis c (hcv) |
| 04/16/2013 | CA2559958C A differentiation- or regeneration-inducing agent for alveoli |
| 04/16/2013 | CA2555036C Antithrombotic compound |
| 04/16/2013 | CA2550581C Antimicrobial composition comprising a peptide derived from k-casein and a divalent cation |
| 04/16/2013 | CA2547569C Recombinant factor viii having increased specific activity |
| 04/16/2013 | CA2542507C Treatment of inflammatory bowel disease |
| 04/16/2013 | CA2527722C Biodegradable poly(beta-amino esters) and uses thereof |
| 04/16/2013 | CA2488821C Methods and compositions for grafting functional loops into a protein |
| 04/16/2013 | CA2484512C Treatment of cataracts and other ophthalmic diseases |
| 04/16/2013 | CA2476846C Method for detection of leptin receptor ligands |
| 04/16/2013 | CA2465973C Posh nucleic acids, polypeptides and related methods |
| 04/16/2013 | CA2419284C Prna chimera |
| 04/16/2013 | CA2379087C Antimicrobial histone h1 compositions, kits, and methods of use thereof |
| 04/16/2013 | CA2361246C Identification of specific differentially expressed antigens |
| 04/16/2013 | CA2271783C Survivin, a protein that inhibits cellular apoptosis, and its modulation |
| 04/11/2013 | WO2013052813A1 Compositions and methods for treating and preventing hyperlipidemia, fatty liver, atherosclerosis and other disorders associated with metabolic syndrome |
| 04/11/2013 | WO2013052689A1 METHODS OF TREATING OR PREVENTING CNS INFLAMMATION BY ADMINISTERING AN INHIBITOR OF eNOS |
| 04/11/2013 | WO2013052507A1 TREATMENT OF OBESITY AND OBESITY-RELATED DISORDERS BY PHARMACOLOGICAL TARGETING OF Kv1.3 POTASSIUM CHANNELS |
| 04/11/2013 | WO2013052498A2 Caspase 9 inhibition and bri2 peptides for treating dementia |
| 04/11/2013 | WO2013052311A1 Fibroblast growth factor 21 variants |
| 04/11/2013 | WO2013052058A1 Antimicrobial compositions and methods of use thereof |
| 04/11/2013 | WO2013051900A2 Blood coagulation factor ⅶ and ⅶa derivatives, conjugates and complexes comprising the same, and use thereof |
| 04/11/2013 | WO2013051767A1 Novel use of angiogenin |
| 04/11/2013 | WO2013051572A1 Sense-improving agent |
| 04/11/2013 | WO2013051531A1 Novel anti-hcv agent |
| 04/11/2013 | WO2013050590A1 Spra1 antimicrobial peptides and uses thereof |
| 04/11/2013 | WO2013050529A2 Use of igf-1 in the modulation of treg cell activity and the treatment and prevention of autoimmune disorders or diseases |
| 04/11/2013 | WO2013050441A1 Methods and pharmaceutical composition for inhibiting or preventing platelet aggregation |
| 04/11/2013 | WO2013050379A1 Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the pancreatic duct system |
| 04/11/2013 | WO2013050378A1 Glp-1 agonist for use in the treatment of stenosis or/and obstruction in the biliary tract |
| 04/11/2013 | WO2013050346A1 Template -fixed peptidomimetics as inhibitors of fpr1 |
| 04/11/2013 | WO2013012811A3 Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides |
| 04/11/2013 | WO2013010048A3 Non-standard insulin analogues |
| 04/11/2013 | WO2013002580A3 Exendin-4 analogue pegylated with polyethylene glycol or derivative thereof, preparation method thereof, and pharmaceutical composition for preventing or treating diabetes, containing same as active ingredient |
| 04/11/2013 | WO2012174478A3 Stable formulations of a hyaluronan-degrading enzyme |
| 04/11/2013 | WO2012170776A3 Methods of determining a patient's prognosis for recurrence of prostate cancer and/or determining a course of treatment for prostate cancer following a radical prostatectomy |
| 04/11/2013 | WO2012068376A3 Keratin compositions for treatment of bone deficiency or injury |
| 04/11/2013 | WO2007056907A9 TRUNCATED GLUCAGON-LIKE PEPTIDE-1 (sGLP-1) AND ITS PREPARING METHOD AND USE |
| 04/11/2013 | WO2001027079A3 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease |
| 04/11/2013 | US20130091591 Artery- and vein-specific proteins and uses therefor |
| 04/11/2013 | US20130090465 ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS |
| 04/11/2013 | US20130090376 Antibodies to tumor associated proteins |
| 04/11/2013 | US20130090374 Methods for the treatment of tay-sachs disease, sandhoff disease, and gm1-gangliosidosis |
| 04/11/2013 | US20130090370 Apoptosis inducer for cancer cell |
| 04/11/2013 | US20130090294 Novel methods of use of hsp70 for increased performance or treatment of hsp70 related disorders |
| 04/11/2013 | US20130090292 Treatment of degenerative joint disease |
| 04/11/2013 | US20130090291 Hemostatic compositions |
| 04/11/2013 | US20130090289 Method of Treatment of Type 2 Diabetes |
| 04/11/2013 | US20130090288 Pharmaceutical compositions containing at least one protein active ingredient protected from digestive enzymes |
| 04/11/2013 | US20130090285 Methods of treatment with glp-1 receptor agonists |
| 04/11/2013 | US20130089927 Hematopoietic Cell E-Selectin/L-Selectin Ligand Polypeptides and Methods of Use Thereof |
| 04/11/2013 | US20130089592 Method of producing a hydrogel |
| 04/11/2013 | US20130089564 Therapeutic Uses of Glandular Kallikrein |
| 04/11/2013 | US20130089561 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 04/11/2013 | US20130089558 Dengue and west nile viruses proteins and genes coding the foregoing, and their use in vaccinal, therapeutic and diagnostic applications |
| 04/11/2013 | US20130089555 ANTI-FcRH5 ANTIBODIES AND IMMUNOCONJUGATES AND METHODS OF USE |
| 04/11/2013 | US20130089553 Method for making heteromultimeric polypeptides |
| 04/11/2013 | US20130089551 Treatment of pulmonary edema |
| 04/11/2013 | US20130089545 Novel compounds and their effects on feeding behaviour |
| 04/11/2013 | US20130089536 Pharmaceutical composition to prevent and treat alzheimer's disease comprising gcp ii mutant |
| 04/11/2013 | US20130089535 Agent for reducing acetaldehyde in oral cavity |
| 04/11/2013 | US20130089534 Methods for assisting anti-cancer drugs |
| 04/11/2013 | US20130089532 Adiponectin production accelerating composition |
| 04/11/2013 | US20130089528 Compositions and methods for preserving insulin-producing cells and insulin production and treating diabetes |
| 04/11/2013 | US20130089525 Antimicrobial compositions and methods of use thereof |
| 04/11/2013 | US20130089520 Macrocyclic Inhibitors Of Hepatitis C Virus |
| 04/11/2013 | US20130089517 Homogeneous preparations of il-28 and il-29 |
| 04/11/2013 | US20130089515 Use of IL-12 and IL-12 Antagonists in the Treatment of Autoimmune Diseases |
| 04/11/2013 | US20130089513 Method of improving efficacy of biological response-modifying proteins and the exemplary muteins |
| 04/11/2013 | US20130089512 Heteroaryl imidazolone derivatives as jak inhibitors |
| 04/11/2013 | US20130089508 Compositions for enhancing nail health |
| 04/11/2013 | DE102011114864A1 Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat A process for producing a homogeneous powder mixture and process for the preparation of an implant and implant |
| 04/11/2013 | CA2851270A1 Dimeric bacteriophage lysins |
| 04/11/2013 | CA2851243A1 Compositions for enhancing nail health |
| 04/11/2013 | CA2851223A1 Blood coagulation factor vii and viia derivatives, conjugates and complexes comprising the same, and use thereof |
| 04/11/2013 | CA2850723A1 Organonitro thioether compounds and medical uses thereof |
| 04/11/2013 | CA2850357A1 Treatment of obesity and obesity-related disorders by pharmacological targeting of kv1.3 potassium channels |
| 04/11/2013 | CA2849754A1 Sensation-improving agent |